• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

反向铁载体可作为抗疟剂。

Reversed siderophores act as antimalarial agents.

作者信息

Shanzer A, Libman J, Lytton S D, Glickstein H, Cabantchik Z I

机构信息

Department of Organic Chemistry, Weizmann Institute of Science, Rehovot, Israel.

出版信息

Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6585-9. doi: 10.1073/pnas.88.15.6585.

DOI:10.1073/pnas.88.15.6585
PMID:1862083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC52131/
Abstract

We describe here a family of biomimetic iron carriers that display high binding efficiency for ferric ions and favorable permeation properties across erythrocytic membranes. These carriers inhibit in vitro growth of Plasmodium falciparum by scavenging intracellular iron. The chemical features were realized by reproducing the iron-binding cavities of natural iron carriers (siderophores) and by systematic substitutions of their hydrophilic envelopes for more hydrophobic ones. In contrast to natural carriers, which participate in receptor-mediated iron uptake in cells and act as growth promoters, our synthetic carriers were designed to penetrate cellular membranes by diffusion, scavenge intracellular iron, and thereby act as growth inhibitors. Based on these properties we designate the compounds reversed siderophores and refer to the specific analogs of the natural ferrichrome as synthetic ferrichromes. The antimalarial activity of the synthetic ferrichromes correlated with their lipophilicity, and this antimalarial activity was averted when the chelators were applied as iron (III) complexes. The sites of synthetic ferrichrome action reside in the intraerythrocytic parasite and not in serum or on normal erythrocyte components. The agents were effective against all stages of parasite growth and against a variety of multidrug-resistant strains of P. falciparum. The most potent agent of this synthetic ferrichrome series, SF1-ileu, was not toxic to mammalian cells in culture and was 15-fold more potent and 20-fold faster acting than desferrioxamine. Taken in toto, these agents constitute a series of promising candidates for future use in malaria chemotherapy.

摘要

我们在此描述了一类仿生铁载体,它们对铁离子具有高结合效率,并对红细胞膜具有良好的渗透特性。这些载体通过清除细胞内铁来抑制恶性疟原虫的体外生长。其化学特性是通过重现天然铁载体(铁载体)的铁结合腔,并将其亲水性包膜系统地替换为更疏水的包膜来实现的。与参与细胞中受体介导的铁摄取并作为生长促进剂的天然载体不同,我们的合成载体被设计为通过扩散穿透细胞膜,清除细胞内铁,从而作为生长抑制剂。基于这些特性,我们将这些化合物称为反向铁载体,并将天然高铁色素的特定类似物称为合成高铁色素。合成高铁色素的抗疟活性与其亲脂性相关,当螯合剂以铁(III)配合物的形式应用时,这种抗疟活性就会消失。合成高铁色素的作用位点位于红细胞内的寄生虫中,而不是血清中或正常红细胞成分上。这些药物对寄生虫生长的各个阶段以及多种耐多药恶性疟原虫菌株均有效。该合成高铁色素系列中最有效的药物SF1-ileu对培养中的哺乳动物细胞无毒,其效力比去铁胺高15倍,作用速度快20倍。总体而言,这些药物构成了未来用于疟疾化疗的一系列有前景的候选药物。

相似文献

1
Reversed siderophores act as antimalarial agents.反向铁载体可作为抗疟剂。
Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6585-9. doi: 10.1073/pnas.88.15.6585.
2
Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum.铁(III)螯合剂作为抗疟药的作用模式。III. 基于异羟肟酸酯的药物对恶性疟原虫体外生长联合作用中的超加性效应。
Mol Pharmacol. 1995 Feb;47(2):403-9.
3
The combined effect of iron chelators and classical antimalarials on the in-vitro growth of Plasmodium falciparum.铁螯合剂与传统抗疟药对恶性疟原虫体外生长的联合作用。
J Antimicrob Chemother. 1992 Sep;30(3):273-8. doi: 10.1093/jac/30.3.273.
4
Mode of action of iron (III) chelators as antimalarials: I. Membrane permeation properties and cytotoxic activity.铁(III)螯合剂作为抗疟药的作用方式:I. 膜渗透特性和细胞毒性活性。
Blood. 1993 Jan 1;81(1):214-21.
5
Chemical Determinants of antimalarial activity of reversed siderophores.反向铁载体抗疟活性的化学决定因素
Antimicrob Agents Chemother. 1996 Sep;40(9):2160-6. doi: 10.1128/AAC.40.9.2160.
6
Iron chelators: mode of action as antimalarials.铁螯合剂:作为抗疟药的作用模式。
Acta Haematol. 1996;95(1):70-7. doi: 10.1159/000203952.
7
Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores.基于异羟肟酸的铁螯合剂的抗疟作用以及反向铁载体对去铁胺作用的增强
Antimicrob Agents Chemother. 1995 Jan;39(1):61-5. doi: 10.1128/AAC.39.1.61.
8
Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparum.铁螯合剂作为抗疟药:二儿茶酚酸对恶性疟原虫的体外活性
J Antimicrob Chemother. 2002 Aug;50(2):177-87. doi: 10.1093/jac/dkf104.
9
Synthesis and evaluation of iron chelators with masked hydrophilic moieties.具有掩蔽亲水基团的铁螯合剂的合成与评价
J Am Chem Soc. 2002 Oct 30;124(43):12666-7. doi: 10.1021/ja027013s.
10
Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria.流式细胞术评估羟基吡啶酮铁螯合剂对耐药疟疾体外生长的影响
Cytometry. 1997 Jan 1;27(1):84-91. doi: 10.1002/(sici)1097-0320(19970101)27:1<84::aid-cyto11>3.0.co;2-o.

引用本文的文献

1
Iron acquisition strategies in pathogenic fungi.致病真菌中的铁获取策略。
mBio. 2025 Jun 11;16(6):e0121125. doi: 10.1128/mbio.01211-25. Epub 2025 May 20.
2
Anti-Malarial and Anti-Lipid Peroxidation Activities of Deferiprone-Resveratrol Hybrid in -Infected Mice.去铁酮-白藜芦醇杂合物在感染小鼠中的抗疟疾和抗脂质过氧化活性
Biology (Basel). 2021 Sep 14;10(9):911. doi: 10.3390/biology10090911.
3
Identifying a Deferiprone-Resveratrol Hybrid as an Effective Lipophilic Anti-Plasmodial Agent.鉴定一种地拉罗司-白藜芦醇杂合物为有效的亲脂性抗疟药物。
Molecules. 2021 Jul 3;26(13):4074. doi: 10.3390/molecules26134074.
4
The relationship of physico-chemical properties and structure to the differential antiplasmodial activity of the cinchona alkaloids.金鸡纳生物碱的物理化学性质及结构与抗疟活性差异之间的关系。
Malar J. 2003 Sep 1;2:26. doi: 10.1186/1475-2875-2-26.
5
Effects of synthetic siderophores on proliferation of Plasmodium falciparum in infected human erythrocytes.合成铁载体对恶性疟原虫在受感染人类红细胞中增殖的影响。
Antimicrob Agents Chemother. 2002 Jun;46(6):2010-3. doi: 10.1128/AAC.46.6.2010-2013.2002.
6
Chemical Determinants of antimalarial activity of reversed siderophores.反向铁载体抗疟活性的化学决定因素
Antimicrob Agents Chemother. 1996 Sep;40(9):2160-6. doi: 10.1128/AAC.40.9.2160.
7
The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites.去铁胺的抗疟作用涉及一条通向红细胞内(恶性疟原虫)寄生虫的直接途径。
J Clin Invest. 1993 Jan;91(1):218-24. doi: 10.1172/JCI116174.
8
Iron chelators as therapeutic agents against Pneumocystis carinii.铁螯合剂作为抗卡氏肺孢子虫的治疗药物。
Antimicrob Agents Chemother. 1994 May;38(5):997-1003. doi: 10.1128/AAC.38.5.997.
9
Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores.基于异羟肟酸的铁螯合剂的抗疟作用以及反向铁载体对去铁胺作用的增强
Antimicrob Agents Chemother. 1995 Jan;39(1):61-5. doi: 10.1128/AAC.39.1.61.
10
Ability of Pseudomonas pseudomallei malleobactin to acquire transferrin-bound, lactoferrin-bound, and cell-derived iron.类鼻疽假单胞菌铁载体获取转铁蛋白结合铁、乳铁蛋白结合铁和细胞源性铁的能力。
Infect Immun. 1993 Feb;61(2):656-62. doi: 10.1128/iai.61.2.656-662.1993.

本文引用的文献

1
Antimalarial activity of selected aromatic chelators. III. 8-Hydroxyquinolines (oxines) substituted in positions 5 and 7, and oxines annelated in position 5,6 by an aromatic ring.
Mol Pharmacol. 1982 Jul;22(1):140-4.
2
Antimalarial activity of selected aromatic chelators. II. Substituted quinolines and quinoline-N-oxides.
Mol Pharmacol. 1981 Jul;20(1):218-23.
3
Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine.恶性疟原虫:去铁胺对其体外生长的抑制作用
Am J Trop Med Hyg. 1982 Sep;31(5):919-22. doi: 10.4269/ajtmh.1982.31.919.
4
Three-dimensional structure of membrane and surface proteins.膜蛋白和表面蛋白的三维结构。
Annu Rev Biochem. 1984;53:595-623. doi: 10.1146/annurev.bi.53.070184.003115.
5
Malaria and iron.
Br J Haematol. 1983 Feb;53(2):181-3. doi: 10.1111/j.1365-2141.1983.tb02009.x.
6
The problem of drug resistance in malaria.疟疾中的耐药性问题。
Parasitology. 1985 Apr;90 ( Pt 4):705-15. doi: 10.1017/s003118200005232x.
7
A reappraisal of the effects of iron and desferrioxamine on the growth of Plasmodium falciparum 'in vitro': the unimportance of serum iron.铁和去铁胺对恶性疟原虫“体外”生长影响的重新评估:血清铁的不重要性
Br J Haematol. 1986 Jun;63(2):273-80. doi: 10.1111/j.1365-2141.1986.tb05550.x.
8
Recent trends in the epidemiology and control of malaria.
Epidemiol Rev. 1987;9:219-43. doi: 10.1093/oxfordjournals.epirev.a036303.
9
Deferoxamine inhibition of malaria is independent of host iron status.去铁胺对疟疾的抑制作用与宿主铁状态无关。
J Exp Med. 1988 Jul 1;168(1):375-87. doi: 10.1084/jem.168.1.375.
10
Antimalarial properties of orally active iron chelators.口服活性铁螯合剂的抗疟特性。
Blood. 1988 Jul;72(1):358-61.